Healthcare -
Biotechnology - NASDAQ - US
$ 5.48
1.48 %
$ 326 M
Market Cap
-7.31
P/E
ALDX - CAPITAL EXPENDITURES
Capital Expenditures ALDX - Aldeyra Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR